🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
3.920
-0.060 (-1.51%)
Nov 20, 2026, 4:00 PM EST - Market closed

ImageneBio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
-0.83.57.96
Revenue Growth
--77.14%-56.04%-
Gross Profit
-0.83.57.96
Selling, General & Admin
22.520.738.397.96
Research & Development
27.5828.5332.1121.93
Operating Expenses
50.0849.2540.529.89
Operating Income
-50.08-48.45-37-21.93
Interest & Investment Income
4.862.040.371.19
Other Non Operating Income (Expenses)
1.660.720.07-0.14
Pretax Income
-43.56-45.7-36.56-20.87
Income Tax Expense
-0.23-0.350.010.28
Net Income
-43.33-45.35-36.57-21.15
Preferred Dividends & Other Adjustments
-7.0511.8210.89
Net Income to Common
-43.33-52.4-48.38-32.04
Net Income Growth
----
Shares Outstanding (Basic)
1352321
Shares Outstanding (Diluted)
1352321
Shares Change
17.63%148.16%-99.32%-
EPS (Basic)
-3.29-9.64-22.10-0.10
EPS (Diluted)
-3.29-9.64-22.10-0.10
EPS Growth
----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Free Cash Flow
-40.61-47.84-21.32-18.54
Free Cash Flow Per Share
-3.09-8.81-9.74-0.06
Gross Margin
-100.00%100.00%100.00%
Operating Margin
--6056.38%-1057.14%-275.37%
Profit Margin
--6549.38%-1382.40%-402.39%
Free Cash Flow Margin
--5980.50%-609.11%-232.83%
EBITDA
-49.39-48.05-35.86-19.52
EBITDA Margin
----245.15%
D&A For EBITDA
0.690.41.142.41
EBIT
-50.08-48.45-37-21.93
EBIT Margin
----275.37%